Learn more about Men's Health
Prostate cancer is a disease so pervasive that many people don’t realize its severity. But it’s the third most common type of cancer, having killed just over 29,000 men in 2018, according to the American Cancer Society. Learn how NewYork-Presbyterian healthcare teams are using a state-of-the-art therapy in clinical trials that precisely targets cancerous prostate tumors without harming other cells. It holds promise for effectively treating men for whom surgery or radiation alone is not necessarily the best option, including men with aggressive tumors. Then discover how Natan Santacruz, a former college athlete, turned his battle against testicular cancer into a career in nursing. Just after celebrating his five-year anniversary of being cancer-free, he became a father for the first time.